Please provide your email address to receive an email when new articles are posted on . Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and ...
(RTTNews) - Eye health company Bausch + Lomb Corp. (BLCO) announced Tuesday the U.S. commercial launch of MIEBO (perfluorohexyloctane ophthalmic solution) for the treatment of the signs and symptoms ...
MIEBO is the First and Only Prescription Eye Drop that Directly Targets Tear Evaporation, the Leading Cause of Dry Eye Disease DED affects more than 38 million Americans, with approximately nine in 10 ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A single drop of Miebo had no significant impact on ...
A Bausch + Lomb drug for dry eye disease is now approved by the FDA, providing a new treatment option for the millions of people whose eyes cannot stay wet and lubricated enough. It’s the first new ...
The US Food and Drug Administration (FDA) has approved a drug to target the excessive tear evaporation associated with dry eye disease. The treatment, MIEBO (perfluorohexyloctane ophthalmic solution, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results